findmyKOL

Evanthia Galanis, MD

Enriched profile

Group Chair, Alliance for Clinical Trials in Oncology; Sandra J. Schulze Professor of Novel Therapeutics and Professor of Oncology, Mayo Clinic · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyMedical OncologyFocusGlioma Diagnosis and Treatment+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2024–2024NIH funding2000–2025

Evanthia Galanis is Group Chair, Alliance for Clinical Trials in Oncology; Sandra J. Schulze Professor of Novel Therapeutics and Professor of Oncology, Mayo Clinic at Mayo Clinic. OpenAlex indexes 431 publications with 27,798 citations (h-index 80); ClinicalTrials.gov lists 25 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Evanthia Galanis, MD, is Group Chair, Alliance for Clinical Trials in Oncology at Mayo Clinic, Rochester, MN. The public record shows 431 publications with 27,798 citations (h-index 80), centered on Glioma Diagnosis and Treatment, Virus-based gene therapy research, Brain Metastases and Treatment. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 2 companies, 13 NIH-funded awards (2000–2025).

  • Most recent indexed publication: 2026 · Nature medicine
  • Top research focus: Glioma Diagnosis and Treatment
  • 25 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neuro-Oncology / Glioma7 trialsSarcoma6 trialsComa6 trialsGliosarcoma5 trialsLung Cancer (NSCLC/SCLC)3 trialsCarcinoma, Transitional Cell2 trialsCarcinoma, Endometrioid2 trialsAdenocarcinoma, Clear Cell2 trialsAdenocarcinoma, Mucinous2 trialsSmall Cell Lung Carcinoma2 trialsCentral Nervous System Neoplasms2 trialsNervous System Neoplasms2 trialsMelanoma2 trialsGlioma2 trialsAstrocytoma2 trialsOligodendroglioma2 trialsProstate Cancer2 trialsBrenner Tumor1 trialBreast Cancer1 trialLymphoma1 trialOvarian / Gynecologic Cancer1 trialMultiple Myeloma1 trialRecurrence1 trialMeningioma1 trialNeural Tube Defects1 trialPancreatic Cancer1 trialCarcinosarcoma1 trial

Research focus

OpenAlex concept fingerprint
Glioma Diagnosis and TreatmentVirus-based gene therapy researchBrain Metastases and TreatmentVirology and Viral DiseasesRadiomics and Machine Learning in Medical Imaging

Works with

trial sponsors and companies reporting payments
Alliance Foundation Trials, LLC.Clinical trials9Industry payments—Boehringer Ingelheim International GmbHClinical trials—Industry payments7National Cancer Institute (NCI)Clinical trials7Industry payments—Alliance for Clinical Trials in OncologyClinical trials4Industry payments—Mayo ClinicClinical trials4Industry payments—Epeius BiotechnologiesClinical trials1Industry payments—Merck Sharp & Dohme LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
431publications

Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.

27,798citations

Total citations across indexed works.

80h-index

Hirsch index (OpenAlex). i10-index 234.

Clinical & industry

trials, payments and federal funding
25clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2024–2024

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
13NIH grants · 2000–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:

All 25 trial records: search, sort and filter.Explore →

Industry payments

Updated 16 Oct 2026

2 companies reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    69.5%
    PD-1 inhibitor33.9%
    Pembrolizumab100%
    Part B, office-administered≥34 patients
    Microtubule Inhibitor19.3%
    Paclitaxel100%
    Part B, office-administered≥24 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    26.5%
    Other antiemetics22.1%
    Fosaprepitant100%
    Part B, office-administered≥31 patients
    Serotonin-3 Receptor Antagonist4.3%
    Palonosetron hcl57%Ondansetron hydrochloride43%
    Part B, office-administered≥53 patients

  • Sensory organs

    3.7%
    Corticosteroid3.7%
    Dexamethasone sodium phosphate100%
    Part B, office-administered≥70 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

13 NIH research awards on record, funded 2000–2025 per NIH RePORTER. The latest:

All 80 award records: search, sort and filter.Explore →

Congress activity

Updated 16 Oct 2026

51 congress contributions (2004–2025) across AACR, ASCO, ASTRO per OpenAlex. The most recent:

All 51 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 24 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
    Article3,841 citations2010
    doi.org ↗
  2. 02
    Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
    Article1,668 citations2016
    doi.org ↗
  3. 03
    Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
    Article1,196 citations2017
    doi.org ↗
  4. 04
    Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
    Article1,149 citations2020
    doi.org ↗
  5. 05
    Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
    Article711 citations2017
    doi.org ↗
All 431 cited works: search, sort and filter.Explore →

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Caterina Giannini83Patrick Y. Wen74Jan C. Buckner71Kurt A. Jaeckle58Stephen J. Russell57Jann N. Sarkaria55David A. Reardon48Paul D. Brown47Timothy J. Kaufmann44S. Keith Anderson44Joon H. Uhm39Michael Weller38Priscilla K. Brastianos35Ianko Iankov34Martin J. van den Bent33David Schiff33Mark J. Federspiel33Karla V. Ballman32Michael A. Vogelbaum32Minesh P. Mehta30Panayiotis J. Papagelopoulos30Kah-Whye Peng30Eudocia Q. Lee27Manmeet S. Ahluwalia27Timothy F. Cloughesy27Ileana Aderca27Benjamin M. Ellingson26Cory Allen26Andrew B. Lassman26Raymond Y. Huang26Paula J. Zollman26Ian F. Parney24Mark A. Schroeder24Keith L. Ligon23Howard Colman23Sandro Santagata22Sani H. Kizilbash22Burt Nabors22Wolfgang Wick22Susan M. Chang22

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/evanthia-galanis-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Evanthia-Galanis-38937787

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/MayoClinic/photos/oncologist-evanthia-galanis-md-is-passionate-about-making-a-difference-and-she-i/10156998954597517

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Facebook

    facebook.com/MayoClinic/posts/as-a-medical-oncologist-evanthia-galanis-md-has-a-simple-philosophy-patients-nee/10156646401227517

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Other

    data.the-asci.org/controllers/asci/DirectoryController.php

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →data.the-asci.org ↗
  • Other

    mayomagazine.mayoclinic.org/2019/11/a-physicians-love-for-philosophy-grows-into-a-passion-for-practicing-medical-oncology-to-help-patients

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayomagazine.mayoclinic.org ↗
  • Other

    allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗
  • Other

    conquer.org/impact/your-stories/priscilla-brastianos-md-and-evanthia-galanis-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →conquer.org ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Athens Medical School

    1990
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mesotheliomadr.com ↗
  • DSc
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗
  • Board Certified

    Medical Oncology (American Board of Internal Medicine)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • M.D.

    National and Kapodistrian University of Athens School of Medicine (Athens University School of Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗
  • Residency

    Internal Medicine, and Fellowship, Hematology/Oncology, Mayo Graduate School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗
  • Board certified

    Internal Medicine and Medical Oncology (American Board of Internal Medicine)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗

Editorial & leadership roles

journal and society appointments
  • President-elect (subsequently active leadership)

    Society for Neuro-Oncology; author/contributor to SNO's 30th-anniversary retrospective

    2026
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic.oup.com ↗
  • Group Chair-Elect

    Alliance for Clinical Trials in Oncology

    2023
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancerletter.com ↗
  • Group Chair

    Alliance for Clinical Trials in Oncology (elected Chair-Elect May 2023; term as Chair began November 2023, six-year term); previously Chair, Alliance Neuro-Oncology Committee, member since 2011

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗
  • Group Chair

    Alliance for Clinical Trials in Oncology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗
  • President

    Alliance Foundation Trials (AFT), LLC

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →allianceforclinicaltrialsinoncology.org ↗
  • Chair

    Alliance Neuro-Oncology Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →allianceforclinicaltrialsinoncology.org ↗
  • Co-chair

    National Cancer Institute Glioblastoma and Brain Metastases Interest Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Leader

    Gene and Virus Therapy Program, Mayo Clinic Comprehensive Cancer Center

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
  • Former leader

    Gene and Virus Therapy Program, Mayo Clinic Comprehensive Cancer Center

    2020
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗
  • Executive Dean for Development

    Mayo Clinic

    2019
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alumniassociation.mayo.edu ↗
  • Chair

    Department of Molecular Medicine, Mayo Clinic

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
  • Former Chair

    Department of Molecular Medicine, Mayo Clinic

    2019
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗
  • Joint appointment

    Division of Medical Oncology - Department of Oncology and Department of Molecular Medicine, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
  • Joint appointment

    Division of Medical Oncology, Department of Oncology, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allianceforclinicaltrialsinoncology.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.